Cargando…

Difficult‐to‐treat asthma patients from ethnic minority groups in central England are at an enhanced risk of house dust mite sensitisation

BACKGROUND: House dust mite (HDM) is the most common sensitising allergen in asthma. Ethnic minority groups (EMGs) in the UK are more likely to live in deprived conditionings with a greater exposure to HDM and other aero‐allergens. AIM: To compare the ethnicity‐based patterns of sensitisation to aer...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansur, Adel H., Marsh, Julie, Bahron, Ali, Thomas, Maximillian, Walters, Gareth, Busby, John, Heaney, Liam G., Krishna, Mamidipudi Thirumala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560749/
https://www.ncbi.nlm.nih.gov/pubmed/37876034
http://dx.doi.org/10.1002/clt2.12303
_version_ 1785117789304913920
author Mansur, Adel H.
Marsh, Julie
Bahron, Ali
Thomas, Maximillian
Walters, Gareth
Busby, John
Heaney, Liam G.
Krishna, Mamidipudi Thirumala
author_facet Mansur, Adel H.
Marsh, Julie
Bahron, Ali
Thomas, Maximillian
Walters, Gareth
Busby, John
Heaney, Liam G.
Krishna, Mamidipudi Thirumala
author_sort Mansur, Adel H.
collection PubMed
description BACKGROUND: House dust mite (HDM) is the most common sensitising allergen in asthma. Ethnic minority groups (EMGs) in the UK are more likely to live in deprived conditionings with a greater exposure to HDM and other aero‐allergens. AIM: To compare the ethnicity‐based patterns of sensitisation to aero‐allergens and the impact of ethnicity on clinical outcomes in patients with difficult‐to‐treat asthma (DTA). METHODS: Data of patients with DTA were extracted from the registry of the Birmingham Regional Severe Asthma Service (BRSAS), which have a catchment population of 7.3million from Central England. Patients from White and EMG backgrounds were compared in terms of the prevalence of atopy, total serum immunoglobulin E (IgE), specific serum IgE (ssIgE) and asthma related clinical outcomes. Logistic regression analysis was conducted to explore ethnicity‐based risk factors for HDM sensitisation. RESULTS: A total of 1272 patients [White 1016 (79.9%), EMG 256 (20.1%) EMG] with a median age of 51 years (range 16–97) were included in the analysis. Patients from EMG were more likely (64%) to reside in the worst scale of index of multiple deprivation (IMD) than the White patients (25.5%), p < 0.0001. Positive HDM sensitisation was more prevalent in the EMG than in the White group [142/216 (66%) versus 375/842 (45%), p < 0.0001]. The median HDM ssIgE level was higher in the EMG than in the White group [3.0 KUA/L (IQR 0.06, 11.5) versus 0.1 (0.01, 3.0), p < 0.000001]. The odds ratio for positive sensitisation to HDM conveyed by the EMG status was 2.61 (95%CI, 1.8–3.8), p < 0.0001. Compared to the White group, the EMG had higher median total serum IgE [326 KU/L (115, 971) versus 114 (29.8, 434.8), p < 0.000001], higher blood eosinophil count (0.36 × 10(9)(0.18, 0.62) versus 0.23 (0.1,0.47), p < 0.000001), were marginally more atopic (79.2% vs. 75.6%, p = 0.098) and were less likely to being on maintenance oral corticosteroids (22% vs. 39.7%, p < 0.0001). CONCLUSION: In this DTA cohort, positive HDM sensitisation was greater amongst the EMG than the White patients. The EMG status was a significant risk factor for HDM sensitisation.
format Online
Article
Text
id pubmed-10560749
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105607492023-10-10 Difficult‐to‐treat asthma patients from ethnic minority groups in central England are at an enhanced risk of house dust mite sensitisation Mansur, Adel H. Marsh, Julie Bahron, Ali Thomas, Maximillian Walters, Gareth Busby, John Heaney, Liam G. Krishna, Mamidipudi Thirumala Clin Transl Allergy Original Article BACKGROUND: House dust mite (HDM) is the most common sensitising allergen in asthma. Ethnic minority groups (EMGs) in the UK are more likely to live in deprived conditionings with a greater exposure to HDM and other aero‐allergens. AIM: To compare the ethnicity‐based patterns of sensitisation to aero‐allergens and the impact of ethnicity on clinical outcomes in patients with difficult‐to‐treat asthma (DTA). METHODS: Data of patients with DTA were extracted from the registry of the Birmingham Regional Severe Asthma Service (BRSAS), which have a catchment population of 7.3million from Central England. Patients from White and EMG backgrounds were compared in terms of the prevalence of atopy, total serum immunoglobulin E (IgE), specific serum IgE (ssIgE) and asthma related clinical outcomes. Logistic regression analysis was conducted to explore ethnicity‐based risk factors for HDM sensitisation. RESULTS: A total of 1272 patients [White 1016 (79.9%), EMG 256 (20.1%) EMG] with a median age of 51 years (range 16–97) were included in the analysis. Patients from EMG were more likely (64%) to reside in the worst scale of index of multiple deprivation (IMD) than the White patients (25.5%), p < 0.0001. Positive HDM sensitisation was more prevalent in the EMG than in the White group [142/216 (66%) versus 375/842 (45%), p < 0.0001]. The median HDM ssIgE level was higher in the EMG than in the White group [3.0 KUA/L (IQR 0.06, 11.5) versus 0.1 (0.01, 3.0), p < 0.000001]. The odds ratio for positive sensitisation to HDM conveyed by the EMG status was 2.61 (95%CI, 1.8–3.8), p < 0.0001. Compared to the White group, the EMG had higher median total serum IgE [326 KU/L (115, 971) versus 114 (29.8, 434.8), p < 0.000001], higher blood eosinophil count (0.36 × 10(9)(0.18, 0.62) versus 0.23 (0.1,0.47), p < 0.000001), were marginally more atopic (79.2% vs. 75.6%, p = 0.098) and were less likely to being on maintenance oral corticosteroids (22% vs. 39.7%, p < 0.0001). CONCLUSION: In this DTA cohort, positive HDM sensitisation was greater amongst the EMG than the White patients. The EMG status was a significant risk factor for HDM sensitisation. John Wiley and Sons Inc. 2023-10-08 /pmc/articles/PMC10560749/ /pubmed/37876034 http://dx.doi.org/10.1002/clt2.12303 Text en © 2023 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mansur, Adel H.
Marsh, Julie
Bahron, Ali
Thomas, Maximillian
Walters, Gareth
Busby, John
Heaney, Liam G.
Krishna, Mamidipudi Thirumala
Difficult‐to‐treat asthma patients from ethnic minority groups in central England are at an enhanced risk of house dust mite sensitisation
title Difficult‐to‐treat asthma patients from ethnic minority groups in central England are at an enhanced risk of house dust mite sensitisation
title_full Difficult‐to‐treat asthma patients from ethnic minority groups in central England are at an enhanced risk of house dust mite sensitisation
title_fullStr Difficult‐to‐treat asthma patients from ethnic minority groups in central England are at an enhanced risk of house dust mite sensitisation
title_full_unstemmed Difficult‐to‐treat asthma patients from ethnic minority groups in central England are at an enhanced risk of house dust mite sensitisation
title_short Difficult‐to‐treat asthma patients from ethnic minority groups in central England are at an enhanced risk of house dust mite sensitisation
title_sort difficult‐to‐treat asthma patients from ethnic minority groups in central england are at an enhanced risk of house dust mite sensitisation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560749/
https://www.ncbi.nlm.nih.gov/pubmed/37876034
http://dx.doi.org/10.1002/clt2.12303
work_keys_str_mv AT mansuradelh difficulttotreatasthmapatientsfromethnicminoritygroupsincentralenglandareatanenhancedriskofhousedustmitesensitisation
AT marshjulie difficulttotreatasthmapatientsfromethnicminoritygroupsincentralenglandareatanenhancedriskofhousedustmitesensitisation
AT bahronali difficulttotreatasthmapatientsfromethnicminoritygroupsincentralenglandareatanenhancedriskofhousedustmitesensitisation
AT thomasmaximillian difficulttotreatasthmapatientsfromethnicminoritygroupsincentralenglandareatanenhancedriskofhousedustmitesensitisation
AT waltersgareth difficulttotreatasthmapatientsfromethnicminoritygroupsincentralenglandareatanenhancedriskofhousedustmitesensitisation
AT busbyjohn difficulttotreatasthmapatientsfromethnicminoritygroupsincentralenglandareatanenhancedriskofhousedustmitesensitisation
AT heaneyliamg difficulttotreatasthmapatientsfromethnicminoritygroupsincentralenglandareatanenhancedriskofhousedustmitesensitisation
AT krishnamamidipudithirumala difficulttotreatasthmapatientsfromethnicminoritygroupsincentralenglandareatanenhancedriskofhousedustmitesensitisation